Skip to main content

Advertisement

SpringerLink
Log in

Clinical usefulness of des-γ-carboxy prothrombin assay in early diagnosis of hepatocellular carcinoma

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Des-γ-carboxy prothrombin (DCP) was evaluated as a serological marker for hepatocellular carcinoma (HCC), particularly in patients with early HCC. In 1192 patients with various diseases, plasma DCP levels were measured by a newly developed enzyme immunoassay method using an anti-DCP monoclonal antibody. Of the 254 patients with HCC, 143 (56%) had abnormal DCP levels of greater than 0.1 AU/ml. In contrast, elevated DCP levels were rarely observed in patients with chronic hepatitis, liver cirrhosis, metastatic liver cancer, and other malignant tumors. Because no correlation was observed between DCP and α-fetoprotein (AFP), the combined measurement of these two complementary markers appears to be useful in the diagnosis of HCC. Since normal levels were observed in 29 of 30 patients (97%) with small liver tumors measuring 2 cm or less in diameter, the diagnostic application of the DCP assay to small liver tumors is limited. However, in patients with tumors larger than 2 cm, the plasma DCP assay may even be more useful than AFP. Among 46 patients with liver cirrhosis or chronic hepatitis who subsequently developed HCC, significantly increased DCP and AFP levels were observed in nine patients (20%) and 14 patients (30%), respectively, when a tumor was detected. When the results of both assays were combined, 19 patients (41%) had elevated levels of one or both markers. Although the plasma DCP assay alone is not sensitive enough to detect early small liver cancers, it could be applied as a complementary tumor marker together with AFP. The use of both these markers together with imaging modalities in the regular follow-up of patients with chronic liver disease who are at high risk for HCC might be of great benefit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Liebman HA, Furie BC, Tong MJ, Blanchard RA, Lo K-J, Lee S-D, Coleman MS, Furie B: Des-γ-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 310:1427–1431, 1984

    Google Scholar 

  2. Motohara K, Kuroki Y, Kan H, Endo F, Matsuda I: Detection of vitamin K deficiency by use of an enzymelinked immunosorbent assay for circulating abnormal prothrombin. Pediatr Res 19:354–357, 1985

    Google Scholar 

  3. Fujiyama S, Morishita T, Yoshida K, Harada T, Kojima N, Hashiguchi O, Sagara K, Motohara K, Matsuda I: Plasma PIVKA-II levels in various liver diseases: With special reference to plasma PIVKA-II as a marker of hepatocellular carcinoma. Jpn J Gastroenterol 82:135, 1985

    Google Scholar 

  4. Fujiyama S, Morishita T, Sagara K, Sato T, Motohara K, Matsuda I: Clinical evaluation of plasma abnormal prothrombin (PIVKA-II) in patients with hepatocellular carcinoma. Hepato-gastroenterol 33:201–205, 1986

    Google Scholar 

  5. Fujiyama S, Morishita T, Hashiguchi O, Sato T: Plasma abnormal prothrombin (des-γ-carboxy prothrombin) as a marker of hepatocellular carcinoma. Cancer 61:1621–1628, 1988

    Google Scholar 

  6. Hattori N, Ohmizo R, Unoura M, Tanaka N, Kobayashi K, The PIVKA-II Collaborative Working Group: Abnormal prothrombin measurements in hepatocellular carcinoma. J Tumor Marker Oncol 3:207–216, 1988

    Google Scholar 

  7. Kodama T, Yokoi T, Arima K, Suga M, Imai K, Yachi A, Takahashi A, Shimamura Y: Clinical significance of abnormal prothrombin (PIVKA-II) in the plasma of patients with hepatocellular carcinoma. Tumor Res 22:63–70, 1987

    Google Scholar 

  8. Tanabe Y, Ohnishi K, Nomura F, Iida S: Plasma abnormal prothrombin levels in patients with small hepatocellular carcinoma. Am J Gastroenterol 83:1386–1389, 1988

    Google Scholar 

  9. Deyashiki Y, Nishioka Y, Takahashi K, Kosaka Y, Suzuki K: Evaluation of des-γ-carboxy prothrombin as a marker protein of hepatocellular carcinoma. Cancer 64:2546–2551, 1989

    Google Scholar 

  10. Tsai S-L, Huang G-T, Yang P-M, Sheu J-C, Sung J-L, Chen D-S: Plasma des-γ-carboxyprothrombin in the early stage of hepatocellular carcinoma. Hepatology 11:481–488, 1990

    Google Scholar 

  11. Soulier J-P, Gozin D, Lefrere J-J: A new method to assay des-γ-carboxyprothrombin. Results obtained in 75 cases of hepatocellular carcinoma. Gastroenterology 91:1258–1262, 1986

    Google Scholar 

  12. Okuda H, Obata H, Nakanishi T, Furukawa R, Hashimoto E: Production of abnormal prothrombin (des-γ-carboxy prothrombin) by hepatocellular carcinoma. J Hepatol 4:357–363, 1987

    Google Scholar 

  13. King MA, Kew MC, Kuyl JM, Atkinson PM: A comparison between des-γ-carboxy prothrombin and α-fetoprotein as markers of hepatocellular carcinoma in southern African blacks. J Gastroenterol Hepatol 4:17–24, 1989

    Google Scholar 

  14. Ho C-H, Lee S-D, Chang H-T, Wu J-C, Tsai Y-T, Lo K-J: Application of des-γ-carboxy prothrombin as a complementary tumor marker with alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Scand J Gastroenterol 24:47–52, 1989

    Google Scholar 

  15. Okuda K, Kotoda K, Obata H, Hayashi N, Hisamitsu T, Tamiya M, Kubo Y, Yakushiji F, Nagata E, Jinnouchi S, Shimokawa Y: Clinical observations during a relatively early stage of hepatocellular carcinoma, with special reference to serum α-fetoprotein levels. Gastroenterology 69:225–234, 1975

    Google Scholar 

  16. Chen D-S, Sung J-L, Sheu J-C, Lai M-Y, How S-W, Hsu H-C, Lee C-S, Wei T-C: Serum α-fetoprotein in the early stages of human hepatocellular carcinoma. Gastroenterology 86:1404–1409, 1984

    Google Scholar 

  17. Cottone M, Turri M, Caltagirone M, Maringhini A, Sciarrino E, Virdone R, Fusco G, Orlando A, Marino L, Pagliaro L: Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and alfafetoprotein: A prospective study. Hepato-gastroenterol 35:101–103, 1988

    Google Scholar 

  18. Lok ASF, Lai C-L: α-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: Role in the early detection of hepatocellular carcinoma. Hepatology 9:110–115, 1989

    Google Scholar 

  19. Tremolda F, Benevegnù L, Drago C, Casarin C, Cechetto A, Realdi G, Ruol A: Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy. Hepato-gastroenterol 36:519–521, 1989

    Google Scholar 

  20. Laurell C-B: Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15:45–52, 1966

    Google Scholar 

  21. Shinagawa T, Ohto M, Kimura K, Tsunetomi S, Morita M, Saisho H, Tsuchiya Y, Saotome N, Karasawa E, Miki M, Ueno T, Okuda K: Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients. Gastroenterology 86:495–502, 1984

    Google Scholar 

  22. Sheu J-C, Sung J-L, Chen D-S, Lai M-Y, Wang T-H, Yu J-Y, Yang P-M, Chuang C-N, Yang P-C, Lee C-S, Hsu H-C, How S-W: Early detection of hepatocellular carcinoma by real-time ultrasonography. A prospective study. Cancer 56:660–666, 1985

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Third Department of Internal Medicine, Kumamoto University Medical School, 1-1, Honjo 1-chome, 860, Kumamoto, Japan

    Shigetoshi Fujiyama MD, Kiyonori Izuno MD, Kazuto Gohshi MD, Junji Shibata MD & Tatsuo Sato MD

Authors
  1. Shigetoshi Fujiyama MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kiyonori Izuno MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kazuto Gohshi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Junji Shibata MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tatsuo Sato MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was supported in part by a grant from the Japanese Society of Hepatology.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fujiyama, S., Izuno, K., Gohshi, K. et al. Clinical usefulness of des-γ-carboxy prothrombin assay in early diagnosis of hepatocellular carcinoma. Digest Dis Sci 36, 1787–1792 (1991). https://doi.org/10.1007/BF01296626

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01296626

Key words

Search

Navigation